Quest Diagnostics Incorporated (BMV:DGX)

Market Cap	363.30B
Revenue (ttm)	199.01B
Net Income (ttm)	17.66B
Shares Out	n/a
EPS (ttm)	156.17
PE Ratio	20.57
Forward PE	16.75
Dividend	61.73 (1.79%)
Ex-Dividend Date	Oct 3, 2025

Volume	2,977
Average Volume	1,104
Open	3,441.00
Previous Close	3,350.00
Day's Range	3,441.00 - 3,450.00
52-Week Range	3,132.50 - 3,450.00
Beta	n/a
RSI	60.80
Earnings Date	Feb 2, 2026

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,...

• Industry: Medical Laboratories
• Founded: 1967
• Employees: 56,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: DGX

Financial Performance

In 2024, Quest Diagnostics's revenue was $9.87 billion, an increase of 6.70% compared to the previous year's $9.25 billion. Earnings were $866.00 million, an increase of 1.88%.

Financial numbers in USD